Table 3.
Predictive accuracy for mortality of cytolysin in comparison with established liver disease markers.
| AUC | Threshold | Sens | Spec | Acc | Prec | PPV | NPV | |
|---|---|---|---|---|---|---|---|---|
| Cytolysin | 0.82 | detectable | 0.75 | 0.89 | 0.78 | 0.95 | 0.95 | 0.53 |
| FIB-4 | 0.69 | 6.53 | 0.82 | 0.71 | 0.80 | 0.92 | 0.92 | 0.50 |
| ABIC | 0.77 | 8.28 | 0.71 | 0.78 | 0.73 | 0.91 | 0.91 | 0.47 |
| Maddrey’s DF | 0.68 | 29.17 | 1.00 | 0.40 | 0.88 | 0.86 | 0.86 | 1.00 |
| MELD | 0.80 | 25.13 | 0.68 | 0.89 | 0.73 | 0.95 | 0.95 | 0.47 |
The best threshold was determined to maximize the youden index (= sensitivity + specificity) for each marker. Cytolysin n=37, FIB-4 n=35, ABIC n=37, Maddrey’s DF n=24, and MELD score n=37. ABIC, Age, serum bilirubin, INR, and serum creatinine score; acc, accuracy; AUC, area under the curve; FIB-4, Fibrosis-4 Index; INR, international normalized ratio; Maddrey’s DF, Maddrey’s discriminant function; MELD, model for end-stage liver disease; NPV, negative predictive value; PPV, positive predictive value; pre, precision; sens, sensitivity; spec, specificity.